In two retrospective studies including a total of 263 patients treated with a standard radiochemotherapy protocol, the increased number of IL-17+ tumor-infiltrating cells in the TME was shown to be an independent factor for poor OS [19, 82]. Here, IL17A is linked to neoplasm.